Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.
Positive Phase 2 End of Study Data with Bel-sar in Early-Stage Choroidal Melanoma; Ongoing Phase 3 CoMpass Trial Recently Received Authorization to Start Enrolling Patients in Europe Multiple...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.34 | -13.0477117819 | 10.27 | 10.3302 | 8.71 | 279444 | 9.15291563 | CS |
4 | -2.55 | -22.212543554 | 11.48 | 11.5125 | 8.71 | 179242 | 10.10462732 | CS |
12 | 1.03 | 13.0379746835 | 7.9 | 12.3782 | 7.26 | 184559 | 9.99790647 | CS |
26 | 1.86 | 26.3083451202 | 7.07 | 12.3782 | 6.63 | 188165 | 8.92565481 | CS |
52 | 0.7 | 8.50546780073 | 8.23 | 12.3782 | 6.63 | 177947 | 8.50836082 | CS |
156 | -13.57 | -60.3111111111 | 22.5 | 24.83 | 5.99 | 121570 | 10.43632299 | CS |
260 | -5.17 | -36.6666666667 | 14.1 | 26.16 | 5.99 | 124646 | 10.74862599 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관